TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: Sensory response amplitude decrease
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Clearance after oral administration
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Median area under the plasma concentration versus time curve
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: First morbid event (M&M)
Endpoint domain: Mortality/survival
Primary endpoint: Unbound estrogen receptors (ER) in myometrium
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Unbound progesterone receptors (PR) in fibroid
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Total estrogen receptors (ER) in myometrium
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Physical function improvement (WOMAC units)
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: intraoperative visualization
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: bowel handling
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: overall ease of the operation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Mortality in dialysis patients with diabetes
Endpoint domain: Mortality/survival
Primary endpoint: Self-assessed vitality
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Mean PI of uterine arteries
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: clinical attachment levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Tinnitus Handicap Inventory (THI) score improvement
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: PaCO₂ levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: First-attempt IV insertion success
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of daily ON time
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Activities of daily living (ADL) scores
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Larsen scores at 12 months
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Social functioning (SF-36)
Endpoint domain: Life impact
Endpoint subdomain: Social functioning
Primary endpoint: General health perception (SF-36)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Infarct Size (IS)
Endpoint domain: Physiological/clinical
Primary endpoint: Left Ventricular Ejection Fraction
Endpoint domain: Physiological/clinical
Primary endpoint: Activity Tolerance
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: reduction in HBV DNA
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Acts of violence perpetration
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Adhesion of Acanthamoeba to lenses
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: functional fitness performance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: changes in weight
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Errors above 10% in calculating PBW
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: mean range of motion
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of hypotension after reperfusion
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Incidence of muscle fasciculations
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neuromuscular outcomes
Primary endpoint: Incidence of paralytic symptoms
Endpoint domain: Adverse events/effects
Primary endpoint: MRT
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: CL
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Paranoia
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Negative beliefs about the self
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Remote Injury (RI)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Monocytes TLR4 expression
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Caries reversal in deciduous dentition
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Caries increment in permanent dentition
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Technical success rate of stent placement
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Clinical success rate within 2 days
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rate of complications (colonic perforation and stent migration)
Endpoint domain: Adverse events/effects
Primary endpoint: SDS global functioning
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: vasoconstriction response to Ang II
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Rates of entry into depression treatment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Likelihood of receiving preferred treatments
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Serum levels of procollagen type III N-terminal propeptide (PIIINP)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Guideline-consistent clinical reasoning
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: hospital admission for persistent tachycardia cardioversion
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: GMI (Growth Modulation Index)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cleared ocular inflammation by day 15
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of subjects who were pain-free at days 1, 3, 8, and 15
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change from baseline in the EF domain score of the IIEF
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Beneficial effect on psoriasis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: haemoglobin concentrations
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: percentage transferrin saturation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Proportion of children needing postoperative piritramide
Endpoint domain: Adverse events/effects
Primary endpoint: Postoperative piritramide dose required
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pain scores during the first 60 minutes after surgery
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: ABC‐C irritability subscale score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rate of intracranial bleeding
Endpoint domain: Adverse events/effects
Primary endpoint: Overall stroke rate
Endpoint domain: Adverse events/effects
Primary endpoint: Incidence rate of TB
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Incidence rate of TB/death
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Uncorrected distance visual acuity (logMAR UDVA)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Corneal aberrations
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mid-frequency aided thresholds
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: APHAB scores
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Time to first COPD exacerbation
Endpoint domain: Mortality/survival
Primary endpoint: Neutrophil counts in sputum
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Mean exacerbation rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: PCA lockout interval demands
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pain during dressing changes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Wound depth reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Immediate recovery time
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Screening participation at 6 months
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Difference in drug costs per patient
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: mean cardiac index after CPB
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: incidence of reperfusion arrhythmias
Endpoint domain: Adverse events/effects
Primary endpoint: Distance walked on postoperative day 1 and 2
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Quality of life ratings
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Family/significant other time burden
Endpoint domain: Resource use
Endpoint subdomain: Societal/carer burden
Primary endpoint: Increase in energy expenditure (EE)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Improved subjective sleep quality
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: Time to peak
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Area-under-the-curve
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Iron concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Sensitivity for detecting aortic dissection
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Specificity for detecting aortic dissection
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Sensitivity for detecting thrombus formation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Annual healthcare costs per participant
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Improvement as rated by blinded evaluators
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Vaginal delivery rate within 24 hours
Endpoint domain: Mortality/survival
Primary endpoint: Requirement for repeat dinoprostone
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Maternal satisfaction with the birth process
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Alteration in leukocyte gene expression
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Inflammation Score (IS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of smokers who quit
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of problem drinkers who improved
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: altered connectivity of large-scale functional networks
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Incidence of ACTH therapy related-adverse effects
Endpoint domain: Adverse events/effects
Primary endpoint: Rates of good efficacy and disappearance of hypsarrhythmia
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: final vision deterioration
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 3-years recurrence-free survival
Endpoint domain: Mortality/survival
Primary endpoint: Incorporation of EPA and DHA in white blood cells
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Serum PGE2 levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Weaning outcome
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Improvement in heartburn symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Quality of life improvement in gastroesophageal reflux disease
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Change in AV plane amplitude
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Efficacy criteria met by cone or tunnel test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Behavioral reaction times to negative stimuli
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: P2 and LPC amplitudes in response to stimuli
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: recurrence of any adenoma
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: recurrence of advanced adenoma
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: SHBG (Sex Hormone-Binding Globulin)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: LDL-C (Low-Density Lipoprotein Cholesterol)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Bioequivalence for steady-state area-under-the-curve
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Peak-to-trough ratio at steady state
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Elimination half-lives
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Full Mouth Plaque Index (FMPI)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Full mouth bleeding on probing (FMBOP)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Absolute Neutrophil Count (ANC) nadir
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: White Blood Cell Count (WBC) nadir
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Serum total cholesterol (total-C) concentrations
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: optimal bowel preparation rates
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Postpartum hemorrhage incidence
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: daily frequency of urinary incontinence episodes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: EVLW measurements
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean total area under the plasma concentration-time curve of simvastatin
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean total area under the plasma concentration-time curve of simvastatin acid
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Elimination half-life of simvastatin
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Target trough concentrations achievement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: PD target attainment (fT > MIC ≥ 60%)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: quit attempt success
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Listening effort
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: Rate of group B streptococcal colonization
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: patient-reported symptomatic resolution at day 5
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: combined symptomatic resolution/microbiological eradication at test of cure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: microbiological eradication at test of cure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: in-segment minimal luminal diameter (MLD)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: mean-term values of the visual scales for pain development
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: mean-term development of life quality
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Change in CRT
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 30-day post-discharge medication adherence
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Hazard of delivering preterm
Endpoint domain: Mortality/survival
Primary endpoint: self-reported mood
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: behavioral displays of attention
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: time spent engaged in activities
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Improvements in KHQ domain scores
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Reductions in incontinence episodes per week
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Visits to the pulmonologist
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: Colour changes (ΔΕ*)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Sorption
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Well-being score
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Hospital Anxiety and Depression Scale scores
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: stooling habits
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: infant behavior
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Elbow flexor muscle strength
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Quality of life (QOL) score changes
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Central contrast sensitivity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Peripheral contrast sensitivity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean daily CPAP use
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Glx concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Reduction in the perimeter of affected limbs
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Overall accuracy of SLNB
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Sensitivity of SLNB
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Negative predictive value of SLNB
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cytokine gene expression modulation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: NRT use during hospitalisation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: NRT use post-discharge
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Treatment response to venlafaxine XR
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of spotting days
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Renal clearance of memantine (CL(R))
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Amount of memantine excreted into the urine (Ae0-24h)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: parent activation
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: education activation
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: quality of school interaction
Endpoint domain: Life impact
Endpoint subdomain: Social functioning
Primary endpoint: Vascular calcification
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Moderately severe depressive symptom episode
Endpoint domain: Adverse events/effects
Primary endpoint: recurrence of E. coli urinary tract infections
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: long-term survival in women with invasive breast carcinoma
Endpoint domain: Mortality/survival
Primary endpoint: creatinine excretion rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Composite of all-cause death, stroke, and major bleeding events
Endpoint domain: Mortality/survival
Primary endpoint: pain score at 12 weeks
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes